Inventor

BILLOT XAVIER

CA11 patents

⚠️ This page may combine multiple inventors who share the name “BILLOT XAVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BIOPROJET SOC CIV

4 patents

US9029357B2May 12, 2015

Benzazole derivatives as histamine H4 receptor ligands

BIOPROJET SOC CIV4 citations71

US12134608B2Nov 5, 2024

Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands

BIOPROJET SOC CIV0 citations61

US11306069B2Apr 19, 2022

Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands

BIOPROJET SOC CIV0 citations61

US9242959B2Jan 26, 2016

(Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications

BIOPROJET SOC CIV0 citations40

MERCK & CO INC

2 patents

US7053085B2May 30, 2006

EP4 receptor agonist, compositions and methods thereof

MERCK & CO INC7 citations73

US7109223B2Sep 19, 2006

Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucoma

MERCK & CO INC5 citations62

BIOPROJECT

1 patent

US9255101B2Feb 9, 2016

6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands

BIOPROJECT25 citations90

MERCK FROSST CANADA LTD

1 patent

US7238710B2Jul 3, 2007

EP4 receptor agonist, compositions and methods thereof

MERCK FROSST CANADA LTD5 citations72

BERREBI-BERTRAND ISABELLE

1 patent

US8802664B2Aug 12, 2014

Benzazole derivatives as histamine H4 receptor ligands

BERREBI-BERTRAND ISABELLE4 citations65

MERCK FROSST CANADA

1 patent

USRE42562EJul 19, 2011

EP4 receptor agonist, compositions and methods thereof

MERCK FROSST CANADA1 citations51

GEMIN X BIOTECHNOLOGIES

1 patent

US7230139B2Jun 12, 2007

Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents

GEMIN X BIOTECHNOLOGIES2 citations43